There is currently a debate about the appropriate approach to prevention of schizophrenia. While many argue that prevention efforts should focus on individuals at high risk of developing the illness, others argue for interventions that would reduce the risk in the whole population. This article situates the debate in a historical context We find its antecedents hi a classic 1940s and 1950s debate between British physicians George Pickering and Robert Platt on hypertension and trace a line from Pickering to the influential concept of population prevention formulated by his student Geoffrey Rose. We then discuss the potential application of population prevention to schizophrenia. The article concludes that population and high-risk prevention strategies can be complementary and that it may be feasible and appropriate to use them in combination.
Consistent with this view, some investigators have sought to identify and prophylactically treat individuals who are at high genetic risk of schizophrenia and show prodromal or nonspecific symptoms (Yung et al. 1995; Tsuang et al. 2002; Yung et al. 2003) . In more recent years, however, this view has been challenged by public health-minded researchers (Jablensky 2000; McGrath 2000; Warner 2001) . Debating the population impact of prevention attempts focused on high-risk groups and on individuals presenting prodromal symptoms, these authors contend that significant reductions in the incidence rate of schizophrenia can best be achieved through interventions at the population level.
In this article, we first situate the present debate about schizophrenia prevention in a historical context. We find its antecedents in a classic 1940s and 1950s debate between British physicians George Pickering and Robert Platt on hypertension. We then describe the influential concept of population prevention formulated by Pickering's student Geoffrey Rose. Next we discuss the implications of Rose's contribution for a population prevention strategy for schizophrenia, discussing the assumptions underlying such a strategy and exploring the potentials and limits of candidate population interventions.
There are echoes of the Platt-Pickering debate in the current debate about prevention of schizophrenia. However, there are also points of convergence between the high-risk and population strategies and a growing recognition that the two can complement each other. We conclude the article with a brief discussion of these convergences and the potential for combining the different preventive strategies.
The Platt 'Pickering Debate The origins of Rose's concept of population prevention can be found in the pioneering work of his Oxford teacher, George Pickering, on the distribution of blood pressure in the population. Today, Pickering is perhaps best remembered for his long, and at times heated, debate with Robert Platt, then president of the Royal College of Physicians, about the nature of hypertension (Swales 1985) . Although this debate in the 1940s and 1950s focused on elevated blood pressure, it also illuminated the more general issues of distribution of risk factors and pathology in populations. These issues are quite relevant for the contemporary debate on the prevention of schizophrenia.
The Platt-Pickering debate started after Robert Platt published his 1947 paper on heredity in hypertension (Platt 1947) . In that report, Platt analyzed the family histories of 116 patients with hypertension, categorized into essential and secondary, and a control group of 71 patients with other disorders. He concluded that a hereditary factor could be found in over 90 percent of the cases with essential hypertension, suggesting an autosomal dominant inheritance pattern.
This view was challenged by Pickering in a series of papers published between 1954 and 1955 (Pickering 1955; Swales 1985) . Pickering used data from general population samples as well as patient family samples to show that, first, the distribution of blood pressure in the general population is unimodal, not bimodal, as predicted by an autosomal dominant inheritance, and, second, that the blood pressures of subjects and their first degree relatives correlated highly across the range of pressures. He concluded that blood pressure is inherited as a graded characteristic and that there is no quantitative difference between the so-called essential hypertension and normality. Thus, designation of a discrete category as essential hypertension is artificial.
In response to these reports, in 1959 Platt published a rebuttal in which he analyzed data on blood pressure recordings of siblings of patients with hypertension (Platt 1959) . If, as he argued, essential hypertension was inherited as an autosomal dominant trait, siblings of patients with essential hypertension would divide into two groups-those who inherited the disorder and those who did not (50% of progeny of patients with a autosomal dominant trait are expected to inherit the trait). In his analysis of the sibling data, Platt in fact did find a bimodal distribution, supporting this view.
The correspondence between these two eminent figures of British medicine continued over the years-Platt finding evidence of bimodality in blood pressure readings from various studies, and Pickering pointing out methodological imperfections in these studies that could produce artificial bimodality, at the same time presenting evidence of continuity in blood pressure measurements across the normotensive and hypertensive groups.
The implications of these two viewpoints for prevention are considerable. If, as Platt proposed, essential hypertension is inherited as an autosomal dominant trait, then prevention should focus on detection and early intervention for high-risk individuals, that is, first degree relatives of patients with hypertension. However, if hypertension is inherited as a polygenic trait and is a multifactorial disease, as Pickering proposed, focusing on the relatives of patients with hypertension would not be adequate. Prevention efforts then should focus on a much larger group of individuals at risk or even the whole population. Pickering himself was aware of the public health implications of his theory:
The hypothesis has several positive contributions to make. In the first place, it holds out the hope that the environmental factors determining the rate of rise of pressure with age will ultimately be recognised and assessed. . . . Because of the relation between raised pressure and raised serum cholesterol to subsequent myocardial infarction in males, the substitution of com oil for other fat in cooking and the restriction of animal fats seem sensible and harmless precautions in middle-aged males whose pressures tend to be a little high. (Pickering 1961 , in Swales 1985 Although Platt's view was favored during most of the period in which this debate continued, Pickering's view eventually prevailed. Today, we view essential hypertension as a multifactorial condition continuous with normal blood pressure. In years that followed the Platt-Pickering debate, Rose (1992) further developed the public health implications of the ideas of his teacher into a theoretical framework for population-based prevention. Rose's views have been very influential in public health. They have also been influential for some of the recent proposals for primary prevention in schizophrenia (McGrath 2000) . A brief review of his views is therefore in order.
Rose on Population Prevention Rose (1992) distinguished between two approaches to prevention: prevention for individuals, and the population strategy of prevention. The aim of prevention for individualsthe high-risk strategy-is to identify individuals who are at increased risk of disease and to focus preventive efforts on this subgroup of the population. An example would be to screen patients in a primary care setting for high serum cholesterol or high blood pressure. These individuals are clearly at increased risk of cardiovascular and cerebrovascular diseases, and a change in lifestyle (e.g., diet, exercise) could potentially reduce the risk of such diseases.
There are many advantages to the high-risk strategy. First, establishing risk factors at the individual level may allow us to match the intervention to the individual's problem and special needs. Thus, it has appeal to the recipients of the intervention as well as the health professionals. Second, the high-risk strategy does not interfere with individuals who are not at increased risk. The overall cost may also be lower because fewer individuals receive the intervention, while the effect may be larger among those who receive the intervention because they would be at a higher risk of developing the disease without the intervention. With all these benefits, why shouldn't one prefer the highrisk strategy of prevention over the population strategy? Rose (1992) answers that despite its impressive benefits for a few, the impact of the high-risk strategy on the total burden of disease in the population is often modest. Most cases of disease in the population occur among those who are at a lower risk compared to the high-risk group simply because the number of individuals at a lower risk far exceeds the high-risk population. The distribution of a risk factor in the population is often widespread and continuous, and increased levels of risk factors are generally associated with higher risk for the disease without clear demarcation between individuals at high risk and individuals at low risk. As Rose (1992) succinctly noted: "If a problem is confined to an identifiable minority and if it can be successfully controlled in isolation, then this approach [the high-risk strategy] is adequate, but it is an inadequate response to a common disease or a widespread cause" (p. 95).
Instead of the high-risk strategy, Rose proposes a population strategy that aims to shift the distribution of risk factors in the whole population. By slightly shifting the distribution of the risk factors, the incidence of the disease in the whole population can be reduced (figure 1). As Rose (1992) argues, even a small shift in the mean would cause significant reduction in the disease rates. For example, a 10 percent fall in the average level of blood cholesterol might reduce the risk of coronary heart disease by a quarter. Another study suggested that a 12 percent increase in the average bone density of the population overall would reduce the risk of fractures by 20 percent (Rose 1992) . Alluding to the pioneering work of his teacher, Pickering, on hypertension, Rose used the example of the relationship between hypertension and stroke to highlight the advantage of the population strategy over the high-risk strategy. A 5 percent reduction in blood pressure across the board may reduce the risk of stroke by 30 percent. In contrast, treating all cases of hypertension, even if this reduces the risk of stroke by half, would reduce the number of cases of stroke in the population by only 15 percent.
The potential benefit of the population strategy for prevention of human diseases has already been realized in the form of major public health initiatives such as fluorination of water, iodination of salt, and seat belts. But this strategy has found limited applications in the mental health field, where the high-risk strategy and early treatment are generally favored. As Rose notes, this is perhaps partly due to the culture of mental health research and practice, which heavily focuses on individual patients rather than on populations.
There have been recent challenges, however, to the focus on the high-risk strategy for prevention of schizophrenia (Jablensky 2000; McGrath 2000; Warner 2001 ). The critics point out several characteristics of the high-risk strategy and early treatment that reduce their yield as preventive interventions.
Alternative Classifications of Prevention Strategies
While we chose to use Rose's classification of prevention strategies as a framework for our discussion, alternative classifications have been proposed and used to classify preventive interventions for schizophrenia. A discussion of these alternative classifications may help to better situate Rose's categories of high-risk and population prevention strategies.
Perhaps the best known classification of preventive interventions originates from the Commission on Chronic Illness (1957). According to this classification, primary preventions are interventions that precede the onset of illness and attempt to avert it, whereas secondary preventions follow the onset and attempt to reduce morbidity through early detection and treatment. Later, tertiary preventions that aim to reduce recurrence or chroniciry of illness were added to this scheme.
An alternative classification was proposed by Gordon (1983) , who categorized prevention efforts into universal, selective, and indicated. In Gordon's words, universal preventions are "all those measures which can be advocated confidently for the general public and which, in many cases, can be applied without professional advice or assistance" (Gordon 1983, p. 108) . Examples include adequate diet, dental hygiene, fluorination of water, and use of seat belts. Selective preventions are used in a subgroup of the population selected on the basis of demographic or other characteristics that are associated with an increased risk of illness. Examples include influenza vaccination for the elderly, hepatitis B vaccination for health care professionals, and avoidance of alcohol in pregnant women. Finally, indicated interventions are those that are "advisable only for persons who, on examination, are found to manifest a risk factor, condition or abnormality that identifies them individually as being at sufficiently high risk to require the 
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preventive intervention" (Gordon 1983, p. 108) . Examples include control of hypertension, dietary measures to reduce hypercholesterolemia, and antitubercular treatment for recent tuberculin skin test converters. Later applications extended the definition of indicated preventions to also include interventions for individuals suffering from prodromal signs and symptoms of illness (Mrazek and Haggerty 1994 ). Gordon's universal interventions clearly correspond to Rose's population strategy, and Gordon's indicated interventions correspond to Rose's high-risk strategy. Selected interventions, however, would in some cases correspond to high risk and in other cases to population prevention. Any one of these classifications may be appropriate in a given instance. The current debate about prevention of schizophrenia fits most easily with the framework utilized by Rose. The central issue in this debate has been whether population strategies or high-risk strategies are more appropriate. Therefore, we adhere to Rose's schema in the discussion below.
High-Risk Strategy for Prevention of Schizophrenia
At first glance, the idea of a focused preventive intervention that would target only individuals at high risk of developing schizophrenia appears quite attractive. The risk factor that has the greatest promise as an indicator for such an intervention is family history. The risk for schizophrenia among first degree relatives of schizophrenic probands is over ten times higher than among the general population, and almost 50 times higher among identical twins. Intervention for the first degree relatives of schizophrenia probands, therefore, seems like a good place to start Such a high-risk intervention, however, would have a number of limitations. First is the low positive predictive value of family history-that is, the low proportion of individuals with a positive family history who will develop schizophrenia. In fact, 80 to 90 percent of the first degree relatives of probands with schizophrenia will never experience the illness. Targeted intervention for a group of individuals unlikely to develop schizophrenia raises ethical issues (Warner 2001 ) because intervention might expose them to stigma or other adverse experiences. Thus, there is a potential for harm.
The second limitation of the high-risk prevention strategy is the large number of individuals who do not meet the high-risk criterion but who will develop the disease. It is estimated that at least two-thirds of patients with schizophrenia have no first degree relatives with the illness (Gottesman 1991). Thus, any high-risk intervention that uses family history as a risk indicator would miss the majority of "high-risk individuals."
A major hurdle for developing risk indicators with high positive predictive value is the relatively low prevalence of schizophrenia in the community. The impact of low prevalence on the accuracy of a test can be demonstrated by the nomogram in figure 2 (Fagan 1975) , which depicts the relationship between prevalence or base rate, the ratio of sensitivity over 1 -specificity, and the positive predictive value. Sensitivity is defined as the proportion of individuals with a positive test result among those who will develop the disease and specificity as the proportion with a negative test result among those who will not develop the disease.
In the hypothetical example of an illness with a prevalence of 0.005 (the average estimated prevalence of schizophrenia globally) (Jablensky 2000) and a risk indicator with sensitivity and specificity of 0.95, less than 0.1 of the individuals identified by the risk indicator will develop the illness (positive predictive value); increasing the sensitivity and specificity of the risk indicator to 0.99 would increase this proportion to about 0.33. Sensitivities and specificities of 0.95 or 0.99 are very high compared to most available screening methods for health problems. As a benchmark, a measure for prodromal symptoms (Bonn Scale for Assessment of Basic Symptoms) had a sensitivity of 0.98 and specificity of 0.59 in a clinical sample (KlosterkOtter et al. 2001) . Using these numbers in the nomogram would give a positive predictive value of less than 0.02 in the community. The problem of low accuracy of prediction of future schizophrenia in the community was also noted by Warner (2001) and Jablensky (2000) and is one of the most formidable obstacles for developing effective high-risk preventions.
Population Strategy for Prevention of Schizophrenia
When contrasted with the high-risk strategy, the concept of a population prevention strategy for schizophrenia has theoretical appeal. First, a population intervention may have multiple health benefits. For example, measles, mumps, rubella (MMR) vaccination could reduce the risk of many adverse health consequences of viral infection, including schizophrenia, in offspring. Similarly, prenatal multivitamin use would have numerous benefits in addition to impact on the risk of neural tube defects and perhaps schizophrenia in offspring. Second, the risk factors targeted do not have to be especially strong or potentthat is, risk factors with high relative risk or odds ratios. The population strategy capitalizes on averting risk factors with small or medium effect that are widely distributed in the population.
The population impact of common although weak risk factors, in comparison with rare although strong ones, was dramatically demonstrated in a study by Mortensen et al. (1999) . These authors compared the impact of place of birth and season of birth, both common risk factors for schizophrenia, with the rare risk factor of family history. The size of the effects for place of birth (e.g., relative risk of 3.7 for birth in Greenland) and season of birth (relative risk of 1.1) was much smaller than that for family history (relative risk of 7.3-59.7 depending on the amount of shared genes). Nevertheless, because of their commonness, the population-attributable risk (PAR) for place and season of birth were 34.6 percent and 10.5 percent, respectively, much higher than the PAR of 5.5 percent for family history. PAR estimates the proportion of cases of schizophrenia that would be prevented if the risk factor could be eliminated.
Implementation of a population strategy, however, is based on some fundamental assumptions. These assumptions also highlight the relevance of epidemiological studies for design and implementation of prevention programs.
Assumptions for a Population Strategy
Successful application of a population strategy for prevention of schizophrenia is based on assumptions about the nature of the risk factors, their population distributions, and their relationship with the disease (Gordon 1983; Rose 1992) . A major assumption is that the risk factor should be causally related to the illness. In the absence of experimental evidence, distinguishing between causes and noncausal correlates is not easy. For instance, while an association between obstetric complications and risk of schizophrenia has been established in a number of studies, it is possible that obstetric complications are in fact noncausal correlates of an inborn liability to schizophrenia. Natural experiments such as the famine of the Dutch Hunger Winter (Susser and Lin 1992) or cohorts with clearly defined exposures and large effects, such as viral infections , provide data highly suggestive of a causal relationship. But, even for these risk factors, causal relationships cannot be unequivocally established at our present level of knowledge. 
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A second assumption is that the intervention would affect the distribution of risk factors for the whole population or a large enough subgroup to justify its costs and the occasional adverse effects. Many population health interventions have these characteristics. Childhood immunization, fluorination of water, iodination of salt, bans on smoking in public places, and so on all benefit large segments of the population. Occasionally, children do develop adverse reactions to immunization (e.g., polio), and some smokers may feel ostracized and excluded as a result of bans on smoking in public places, but the benefits of these interventions for the society as a whole outweigh these adverse outcomes.
Finally, any intervention, whether high risk or population level, ultimately assumes that the targeted risk factor is truly modifiable. If a risk factor proves to be impervious to intervention, then any investment of time and money in a program aiming at its eradication or reduction would be wasted. Some of the common risk factors for illnesses are clearly preventable, such as tobacco use, high cholesterol level, and exposure to environmental pollutants. Others, such as genetic risk factors, may be impossible to change at our current level of technology. Change of other malleable risk factors may be infeasible in a certain context for ethical or practical reasons. This latter group may include socially determined phenomena such as living in a rural or urban setting.
At the current state of knowledge, none of the candidate risk factors for population prevention of schizophrenia meets all assumptions. Nonetheless, if the proposed interventions are beneficial public healdi measures in general, we may not necessarily require certainty about their effect in preventing schizophrenia to advocate for them. As Rose (1992) argued, Certainty is not a prerequisite for action. A sick patient can expect from the physician only a reasonable confidence that the diagnosis is right and that the treatment is likely to do more good than harm. Prevention should be judged in the same way, so that action may then proceed alongside continuing research and evaluation, recognizing that new evidence may mean a change of policy, (p. Ill)
Candidate Population Preventions for Schizophrenia
Over the decades, a number of putative risk factors for schizophrenia have been identified. These risk factors span a wide age range-from the prenatal period to young adulthood-and different dimensions-from biological to psychosocial. Some of these risk factors could serve as potential targets for prevention. With the coming of age of large birth cohorts and advances in biological psychiatry, the number of candidate risk factors will likely grow, presenting new opportunities for prevention. Below, we discuss some examples of potential interventions from different time points across the life course. Warner (2001) and Faraone et al. (2002) offer further examples.
Prenatal health may be promoted by a gamut of interventions addressing a variety of putative risk factors for schizophrenia, including obstetric complications (Geddes and Lawrie 1995; Geddes et al. 1999) , nutritional factors Lin 1992), prenatal infections (McGrath and Castle 1995; Brown et al. 2001) , and maternal mental health (Copper et al. 1996; Hedegaard et al. 1996) . Even if only some or none of these are proven to be important risk factors for schizophrenia, improving prenatal health would still be a justified intervention. Prevention of obstetric complications was discussed by Warner (2001) in some detail. Here we briefly discuss prenatal nutrition and immunization.
The value of prenatal nutrition was highlighted by a major public health initiative for prevention of congenital neural tube defects initiated by the Food and Drug Administration (FDA). Based on reports linking low maternal folate levels with neural tube defects, in 1998 the FDA required that folate be added to all cereal grain products sold in the United States. Likely as a result of this intervention, the serum folate levels in reproductive-age women dramatically increased (Erickson et al. 2002) and the rate of neural tube defects declined. Assessments conducted before and after mandated folate fortification policy revealed a decrease of 31 percent in the prevalence of spina bifida and 16 percent in anencephaly (Williams et al. 2002) . This health policy initiative may have implications for prevention of schizophrenia as well because maternal deficiency of folate as well as other micronutrients is hypothesized to play a role in the etiology of at least some cases of schizophrenia (Brown et al. 1996; Mattson and Shea 2003) .
The value of public immunization programs is implied by the growing body of knowledge about the association of different maternal viral infections and schizophrenia. The data on prenatal rubella are particularly significant. In a longitudinal study of a birth cohort of children with congenital rubella assessed over 30 years later, 21 percent met the criteria for a schizophrenia spectrum disorder . The impact of prevention of prenatal rubella could be pronounced in the developing world, where population immunization rates lag far behind the rates in the industrialized world.
Population prevention is not without risks. Even when a population prevention has demonstrated overall benefits to prenatal heakh, one has to carefully consider the potential adverse effects of linking it to schizophrenia. Thus, for example, poorly conducted public information campaigns could be misinterpreted as suggesting that mothers of schizophrenia patients carry blame for their child's illness because of some prenatal condition. It is important to ensure that this perceived blame assignment does not happen. Incorporating a prevention program for schizophrenia in a global health initiative may diminish this risk by deemphasizing the link with any specific disease.
Childhood interventions ranging from injury prevention to cognitive and behavioral remediation programs also hold promise for prevention of schizophrenia. An association between head injury, especially in childhood, and risk of subsequent schizophrenia has been reported (e.g., Malaspina et al. 2001a) . A recent study found a two times higher prevalence of premorbid head trauma among individuals with schizophrenia compared to their normal siblings (AbdelMalik et al. 2003) . Prevention of such injury is feasible through educational and public safety interventions such as building safe playgrounds and distributing helmets. The effectiveness of such interventions for reducing childhood injuries is supported by the results of the Harlem Hospital Injury Prevention Program in northern Manhattan (Durkin et al. 1999) . During the intervention period, the incidence of pediatric injuries declined by 45 percent.
Behavioral and cognitive abnormalities in the childhood histories of individuals who subsequently developed schizophrenia were noted early on (Kraepelin 1919). These associations were verified in more recent birth cohort studies. For example, using data from a British birth cohort, Jones et al. (1994) reported that solitary play preference at ages four and six was about two times more common among children who later developed schizophrenia than other children. In adolescent years, self-rated and teacher-rated anxiety was associated with risk of future schizophrenia. While remediation of cognitive and behavioral precursors of other childhood mental and behavioral conditions has been promising (Kellam et al. 1991; Mrazek and Haggerty 1994; Rebok et al. 1996; Conduct Problems Prevention Research Group 2000) , it remains to be seen whether remediation of childhood cognitive and behavioral deficits would affect the risk of schizophrenia as well.
Adolescent cannabis abuse prevention is also justified for reasons far beyond prevention of schizophrenia. Cannabis is the most common illicit drug of abuse in the United States. In the year 2000, 24 percent of young adults aged 18 to 25 reported using marijuana at least once during the past year (SAMHSA 2001) . The prevalence among youths aged 12 to 17 was 13 percent. An association between cannabis use and schizophrenia has been noted for many years (Thornicroft 1990) . The link has been further supported in recent years by a number of longitudinal studies from various settings (Arseneault et al. 2002; Van Os et al. 2002; Zammit et al. 2002) . At the same time, the efficacy of interventions for reducing the risk of cannabis use in youth has been demonstrated (Hansen and Graham 1991; Mrazek and Haggerty 1994; Lafferty 1998 ). For example, in a large population intervention for drug use, the Adolescent Alcohol Prevention Trial (Hansen and Graham 1991) , students who received an educational intervention promoting norms against drug use showed a three times lower rate of initiation of marijuana use compared to students who did not receive this intervention.
The potential interventions discussed here are only a few in the list of candidate interventions. With growing knowledge about the risk factors for schizophrenia, the list will likely grow and incorporate other social, environmental, and biological risk factors (Hollister et al. 1996; Schaefer et al. 2000; Malaspina et al. 20016 ).
Convergence of Population and High-Risk Prevention
This article contrasts two approaches to prevention. There are, however, many points of convergence between the two approaches, and sometimes there are good reasons to combine them. Theoretically, results from high-risk interventions can inform design of population interventions. Practically, high-risk and population interventions may have a synergistic effect when combined. A case in point is the Fast Track program for prevention of antisocial behavior in schoolchildren (Conduct Problems Prevention Research Group 2000) . This program combined a population intervention with a high-risk intervention in a 5-year school-based randomized trial. Early results from this study indicate significant impact on both the high-risk group and the other children who received the population intervention (Conduct Problems Prevention Research Group 2000) .
While the development of effective population interventions for schizophrenia is anticipated, high-risk intervention should continue (Warner and McGorry 2002) . It is unlikely that, even with the most effective population preventions, schizophrenia will be eradicated. Therefore, for the foreseeable future, there will always be individuals who are at prodromal or very early stages of illness. Detection and early treatment of these individuals could potentially avert the full-blown illness or ameliorate its course. It is to be hoped that these interventions would eventually be joined by effective population interventions and that a comprehensive prevention would combine the benefits of these strategies.
The Way Ahead
It is sobering to note that the major population health status advances in industrialized countries in the late 19th and early 20th centuries were primarily due to overall improvement in these populations' living conditions. Similarly, many of the aims of population prevention of mental disorders in general and schizophrenia in particular may be achieved through improvement in prenatal health (Meberg and Broch 1995; Moutquin 1999; Erickson et al. 2002) or reduction in youth drug use (Sussman et al. 2002) .
Perhaps the strongest argument for the candidate population interventions discussed above is their convergence with the broader public health agenda. This convergence provides unique opportunities for collaboration between mental health professionals and public health practitioners, researchers, and policy makers. Future progress in primary prevention of mental disorders may ultimately depend on the success of the mental health field in forming such collaborations and working toward common goals.
